跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cisbil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cisbil
Approved
STANDARD
Cisbil
SP Accure Labs Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
35b49a50614979a3
Company
SP Accure Labs Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
35b49a50614979a3
Drug Approval Philippines Name
Cisbil
Product Name
Cisbil
Registration Number
DR-XY47492
Brand Name
Cisbil
Generic Name
Cisplatin
Dosage Form
Concentrate for Solution for Intravenous Infusion
Dosage Strength
1 mg/mL (10 mg/ 10 mL)
Manufacturer
SP Accure Labs Pvt. Ltd.
Trader
Abil Chempharma Pvt. Ltd
Importer
Hexagon Pharmaceuticals
Distributor
Hexagon Pharmaceuticals
Issuance Date
26 October 2021
Expiry Date
26 October 2026
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
35b49a50614979a3
Type
Standard
Back to Philippines FDA Approvals